Healthy adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) All subjects voluntarily signed the informed consent after detailed description and understanding of this study 2) Those who belong to a particular university. 3) Subjects with fasting blood glucose level within normal range between 70 mg/dL and 110 mg/dL using the first blood test 4) Subjects with systolic blood pressure under 140 mmHg and diastolic blood pressure under 90 mm Hg 5) Subjects with BMI above 18.5 kg/ m2-under 30 kg/ m2 6) Females who have a regular menstrual cycle, which is 25 to 38 days, and at the first test, who are from 14 days after the start of their menstruation to the next menstruation. 7) Non-smokers
Exclusion criteria
Exclusion criteria: 1) Those who administer ''Food for Specified Health Use'', ''Foods with Function Claims'' or medicine to have effects on blood glucose metabolism. 2) Patients with diseases undergoing treatments or with medical history of severe diseases. 3) Patients who have severe diseases: diabetes, liver disease, kidney disease, heart disease (or persons who have history of these diseases). 4) Those who may suffer from allergy by administering milk, soybean, or cacao mass (chocolate). 5) Subjects who are in pregnancy, lactation. 6) Those who were included other clinical trials within one month before giving written informed consent, or during this study. 7) Any other medical and/or health reasons unfavorable to participation in this study, as judged by the principal investigator or examination doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose level, the blood glucose areas under the curve (AUC), the maximum blood glucose level(Cmax) , and time to reach Cmax(Tmax) | — |
Countries
Japan
Contacts
Meiji Co., Ltd. Group2, Food Science & Technology Research Laboratories, R&D Division